Ligand Pharmaceuticals Incorporated (LGND)
Jul 2, 2025 - LGND was delisted (reason: merged into PTHS)
113.30
+0.74 (0.66%)
Inactive · Last trade price on Jul 2, 2025
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$2,668,941
Profits / Employee
-$1,950,324
Market Cap
2.19B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | 155 | 40 | 34.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
LGND News
- 1 day ago - Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewsWire
- 8 days ago - Ligand to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewsWire
- 22 days ago - Ligand Partner Pelthos Therapeutics Launches ZELSUVMI™ - GlobeNewsWire
- 4 weeks ago - Pelthos Therapeutics Completes Merger with Channel Therapeutics and Closes $50.1 Million Private Placement - GlobeNewsWire
- 4 weeks ago - Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics - GlobeNewsWire
- 5 weeks ago - Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha
- 7 weeks ago - Ligand Announces 2025 Investor Day in New York City - GlobeNewsWire
- 2 months ago - Ligand to Ring the Nasdaq Opening Bell on May 19, 2025 - GlobeNewsWire